![]() Photocure Photocure engages in the research, development, production, distribution of pharmaceutical products and related technical medical equipment. | ![]() Medexus Pharma Medexus Pharma is a pharmaceutical company developing therapies for autoimmune diseases and cancer. | ![]() ESSA Pharma ESSA Pharma is a pharmaceutical company focused on developing therapies for the treatment of prostate cancer. | ||
Founding Date | Founding Date 1978 | Founding Date 1997 | Founding Date 2012 | Founding Date 2009 |
Type | Type Public | Type Public | Type Subsidiary | Type Public |
Tags | ||||
Locations | Locations Hyderabad, IN HQ Hyderabad, IN Hyderabad, IN Hyderabad, IN Hyderabad, IN Visakhapatnam, IN Visakhapatnam, IN see more | Locations Ullern, NO HQ Düsseldorf, DE Princeton, US | Locations Chicago, US HQ | Locations Vancouver, CA HQ Houston, US South San Francisco, US |
Employees | Employees 4,217 | Employees 99 | Employees 106 | Employees 35 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 127.5 m | Valuation ($) N/A | Valuation ($) 240 m |
Financial | ||||
Revenue (est.) | Revenue (est.) ₹64.3b (FY, 2026) | Revenue (est.) kr532.6m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods ₹22.4b (FY, 2026) | Cost of goods kr29.2m (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit ₹45b (FY, 2026) | Gross profit kr503.4m (FY, 2025) | Gross profit N/A | Gross profit N/A |
Net income | Net income ₹10.3b (FY, 2026) | Net income (kr1.5m) (FY, 2025) | Net income N/A | Net income ($28.5m) (FY, 2024) |
Funding | ||||
Total funding raised | Total funding raised $ 200m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 74.1m |

Photocure engages in the research, development, production, distribution of pharmaceutical products and related technical medical equipment.
View company
Medexus Pharma is a pharmaceutical company developing therapies for autoimmune diseases and cancer.
View company
ESSA Pharma is a pharmaceutical company focused on developing therapies for the treatment of prostate cancer.
View company